Trials / Completed
CompletedNCT06564961
Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia
The Effect of Clomiphene Citrate on Sperm Parameters in Infertile Men With Idiopathic Oligoasthenozoospermia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Shakeela Ishrat · Academic / Other
- Sex
- Male
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It will also learn about the safety of clomiphene citrate. The main questions it aims to answer are: * Does drug clomiphene citrate change sperm count and motility in infertile men with idiopathic oligoasthenozoospermia? * What medical problems do participants have when taking drug clomiphene citrate? Researchers will compare drug clomiphene citrate to a placebo (a look-alike substance that contains no drug) to see if drug clomiphene citrate works to treat idiopathic oligoasthenozoospermia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clomiphene Citrate | 50 mg tab once daily |
| DRUG | Placebo | 1 tab once daily |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
- First posted
- 2024-08-21
- Last updated
- 2024-08-23
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT06564961. Inclusion in this directory is not an endorsement.